Evolution of DOHaD: The impact of environmental health sciences

Journal of Developmental Origins of Health and Disease

Volumn 6, Issue 2, 2015, Pages 55-64

  Haugen, A C ^a   Schug, T T ^a   Collman, G ^a   Heindel, J J ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

development; DOHaD; environmental health; exposures; portfolio analysis

Indexed keywords

ANIMAL; GENETIC EPIGENESIS; HUMAN; PREMATURITY;

ANIMALS; EPIGENESIS, GENETIC; HUMANS; PREMATURE BIRTH;

EID: 84928210914     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174414000580     Document Type: Review

References (64)

1. Ravelli GP, Stein ZA, Susser MW. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med. 1976; 295, 349-353.
2. Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986; 1, 1077-1081.
3. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet. 1989; 2, 577-580.
4. Barker DJ. Deprivation in infancy and risk of ischaemic heart disease. Lancet. 1991; 337, 981.
5. Barker DJ, Gluckman PD, Godfrey KM, et al. Fetal nutrition and cardiovascular disease in adult life. Lancet. 1993; 341, 938-941.
6. McLachlan JA, Newbold RR, Bullock BC. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res. 1980; 40, 3988-3999.
7. Newbold RR, Bullock BC, McLachlan JA. Progressive proliferative changes in the oviduct of mice following developmental exposure to diethylstilbestrol. Teratog Carcinog Mutagen. 1985; 5, 473-480.
8. Burbacher TM, Rodier PM, Weiss B. Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. Neurotoxicol Teratol. 1990; 12, 191-202.
9. Gilbert SG, Grant-Webster KS. Neurobehavioral effects of developmental methylmercury exposure. Environ Health Perspect. 1995; 103(Suppl. 6), 135-142.
10. Bellinger D, Sloman J, Leviton A, et al. Low-level lead exposure and children's cognitive function in the preschool years. Pediatrics. 1991; 87, 219-227.
11. Bellinger D, Dietrich KN. Low-level lead exposure and cognitive function in children. Pediatr Ann. 1994; 23, 600-605.
12. Banks EC, Ferretti LE, Shucard DW. Effects of low level lead exposure on cognitive function in children: a review of behavioral, neuropsychological and biological evidence. Neurotoxicology. 1997; 18, 237-281.
13. Needleman HL, Schell A, Bellinger D, Leviton A, Allred EN. The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. N Engl J Med. 1990; 322, 83-88.
14. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science. 2001; 291, 1304-1351.
15. Wadhwa PD, Buss C, Entringer S, Swanson JM. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med. 2009; 27, 358-368.
16. Callinan PA, Feinberg AP. The emerging science of epigenomics. Hum Mol Genet. 2006; 15(Spec No. 1), R95-R101.
17. Huang WW, Yin Y, Bi Q, et al. Developmental diethylstilbestrol exposure alters genetic pathways of uterine cytodifferentiation. Mol Endocrinol. 2005; 19, 669-682.
18. Lehmann KP, Phillips S, Sar M, Foster PM, Gaido KW. Dose-dependent alterations in gene expression and testosterone synthesis in the fetal testes of male rats exposed to di (n-butyl) phthalate. Toxicol Sci. 2004; 81, 60-68.
19. Ruden DM, Xiao L, Garfinkel MD, Lu X. Hsp90 and environmental impacts on epigenetic states: a model for the transgenerational effects of diethylstibesterol on uterine development and cancer. Hum Mol Genet. 2005; 14(Spec No. 1), R149-R155.
20. Bhattacherjee V, Mukhopadhyay P, Singh S, et al. Neural crest and mesoderm lineage-dependent gene expression in orofacial development. Differentiation. 2007; 75, 463-477.
21. Dolinoy DC, Weidman JR, Jirtle RL. Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol. 2007; 23, 297-307.
22. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A. 2007; 104, 13056-13061.
23. Grun F, Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology. 2006; 147(Suppl.), S50-S55.
24. Keri RA, Ho SM, Hunt PA, et al. An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod Toxicol. 2007; 24, 240-252.
25. Schug TT, Janesick A, Blumberg B, Heindel JJ. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol. 2011; 127, 204-215.
26. Soto AM, Maffini MV, Sonnenschein C. Neoplasia as development gone awry: the role of endocrine disruptors. Int J Androl. 2008; 31, 288-293.
27. Janesick A, Blumberg B. Obesogens, stem cells and the developmental programming of obesity. Int J Androl. 2012; 35, 437-448.
28. Heindel JJ, McAllister KA, Worth L Jr, Tyson FL. Environmental epigenomics, imprinting and disease susceptibility. Epigenetics. 2006; 1, 1-6.
29. Kang ER, Iqbal K, Tran DA, et al. Effects of endocrine disruptors on imprinted gene expression in the mouse embryo. Epigenetics. 2011; 6, 937-950.
30. Grandjean P, Weihe P. Developmental origins of environmentally induced disease and dysfunction International Conference on Foetal Programming and Developmental Toxicity, Torshavn, Faroe Islands, 20-24 May, 2007. Basic Clin Pharmacol Toxicol. 2008; 102, 71-72.
31. Darney S, Fowler B, Grandjean P, et al. Prenatal Programming and Toxicity II (PPTOX II): role of environmental stressors in the developmental origins of disease. Reprod Toxicol. 2011; 31, 271.
32. Schug TT, Barouki R, Gluckman P, et al. PPTOX III: environmental stressors in the developmental origins of disease: evidence and mechanisms. Toxicol Sci. 2013; 131, 343-350.
33. Barouki R, Gluckman PD, Grandjean P, Hanson M, Heindel JJ. Developmental origins of non-communicable disease: implications for research and public health. Environ Health. 2012; 11, 42 (http://www.ehjournal.net/content/11/1/42).
34. Needleman HL, McFarland C, Ness RB, Fienberg SE, Tobin MJ. Bone lead levels in adjudicated delinquents. A case control study. Neurotoxicol Teratol. 2002; 24, 711-717.
35. Needleman HL, Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB. Bone lead levels and delinquent behavior. JAMA. 1996; 275, 363-369.
36. Dietrich KN, Succop PA, Berger OG, Hammond PB, Bornschein RL. Lead exposure and the cognitive development of urban preschool children: the Cincinnati Lead Study cohort at age 4 years. Neurotoxicol Teratol. 1991; 13, 203-211.
37. Lanphear BP, Hornung R, Khoury J, et al. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect. 2005; 113, 894-899.
38. Pounds JG, Long GJ, Rosen JF. Cellular and molecular toxicity of lead in bone. Environ Health Perspect. 1991; 91, 17-32.
39. Rice DC, Evangelista de Duffard AM, Duffard R, et al. Lessons for neurotoxicology from selected model compounds: SGOMSEC joint report. Environ Health Perspect. 1996; 104 (Suppl. 2), 205-215.
40. Torres-Sanchez LE, Berkowitz G, Lopez-Carrillo L, et al. Intrauterine lead exposure and preterm birth. Environ Res. 1999; 81, 297-301.
41. Haynes EN, Chen A, Ryan P, et al. Exposure to airborne metals and particulate matter and risk for youth adjudicated for criminal activity. Environ Res. 2011; 111, 1243-1248.
42. Grandjean P, White RF. Neurobehavioral dysfunction as a possible sentinel of methylmercury exposure. Hum Ecol Risk Assess. 2001; 7, 1079-1089.
43. Grandjean P, Weihe P, Needham LL, et al. Relation of a seafood diet to mercury, selenium, arsenic, and polychlorinated biphenyl and other organochlorine concentrations in human milk. Environ Res. 1995; 71, 29-38.
44. Dalgard C, Grandjean P, Jorgensen PJ, Weihe P. Mercury in the umbilical cord: implications for risk assessment for minamata disease. Environ Health Perspect. 1994; 102, 548-550.
45. Grandjean P, Weihe P. Neurobehavioral effects of intrauterine mercury exposure: potential sources of bias. Environ Res. 1993; 61, 176-183.
46. Grandjean P, Weihe P, Jorgensen PJ, et al. Impact of maternal seafood diet on fetal exposure to mercury, selenium, and lead. Arch Environ Health. 1992; 47, 185-195.
47. Grandjean P, Weihe P, White RF, et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol. 1997; 19, 417-428.
48. Rice DC. The US EPA reference dose for methylmercury: sources of uncertainty. Environ Res. 2004; 95, 406-413.
49. Murata K, Budtz-Jorgensen E, Grandjean P. Benchmark dose calculations for methylmercury-associated delays on evoked potential latencies in two cohorts of children. Risk Anal. 2002; 22, 465-474.
50. Budtz-Jorgensen E, Grandjean P, Keiding N, White RF, Weihe P. Benchmark dose calculations of methylmercury-associated neurobehavioural deficits. Toxicol Lett. 2000; 112-113, 193-199.
51. Budtz-Jorgensen E, Grandjean P, Weihe P. Separation of risks and bene fits of seafood intake. Environ Health Perspect. 2007; 115, 323-327.
52. McGivern RF, Sokol RZ, Berman NG. Prenatal lead exposure in the rat during the third week of gestation: long-term behavioral, physiological, and anatomical effects associated with reproduction. Toxicol Appl Pharmacol. 1991; 110, 206-215.
53. Crews D, Gore AC, Hsu TS, et al. Transgenerational epigenetic imprints on mate preference. Proc Natl Acad Sci U S A. 2007; 104, 5942-5946.
54. Anway MD, Rekow SS, Skinner MK. Transgenerational epigenetic programming of the embryonic testis transcriptome. Genomics. 2008; 91, 30-40.
55. Guerrero-Bosagna C, Settles M, Lucker B, Skinner MK. Epigenetic transgenerational actions of vinclozolin on promoter regions of the sperm epigenome. PLoS One. 2010; 5, e13100.
56. Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab. 2010; 21, 214-222.
57. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science. 2005; 308, 1466-1469.
58. Birnbaum LS. NIEHS's new strategic plan. Environ Health Perspect. 2012; 120, a298.
59. Rutter M, Jones RR (eds). Lead versus health: sources and effects of low level lead exposure. Arch Dis Child. 1983; 58, 759.
60. Skinner MK, Anway MD, Savenkova MI, Gore AC, Crews D. Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior. PLoS One. 2008; 3, e3745.
61. Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of endocrine disruptors. Reprod Toxicol. 2011; 31, 337-343.
62. Wolstenholme JT, Edwards M, Shetty SR, et al.Gestational exposure to bisphenol a produces transgenerational changes in behaviors and gene expression. Endocrinology. 2012; 153, 3828-3838.
63. Wolstenholme JT, Taylor JA, Shetty SR, et al. Gestational exposure to low dose bisphenol A alters social behavior in juvenile mice. PLoS One. 2011; 6, e25448.
64. Wolstenholme JT, Rissman EF, Connelly JJ. The role of bisphenol A in shaping the brain, epigenome and behavior. Horm Behav. 2011; 59, 296-305.